X4 Pharmaceuticals

1. 4WARD CN enrollment done4Q 20264WARD CN enrollment done, 4Q 2026, routine
2. K2 loan agreement corporate update4Q 2026K2 loan agreement corporate update, 4Q 2026, routine
3. X4 Pharmaceuticals corporate updateNov 2026X4 Pharmaceuticals corporate update, Nov 2026, routine
4. mavorixafor XOLREMDI corporate updateNov 2026mavorixafor XOLREMDI corporate update, Nov 2026, routine
5. X4 Pharmaceuticals corporate updateNov 30, 2026X4 Pharmaceuticals corporate update, Nov 30, 2026, routine
6. mavorixafor XOLREMDI) commercial launch2027mavorixafor XOLREMDI) commercial launch, 2027, routine
7. 4WARD CN topline1H 20284WARD CN topline, 1H 2028, thesis-defining
8. mavorixafor XOLREMDI filingApr 26, 2028mavorixafor XOLREMDI filing, Apr 26, 2028, notable

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.